Lykos Therapeutics has raised $100M in an oversubscribed Series A funding led by Helena, a global problem-solving organization and investor, with participation from other mission-aligned and institutional investors, including, but not limited to: the Steven & Alexandra Cohen Foundation (led by Alex Cohen), Eir Therapeutics, Vine Ventures, True Ventures, Unlikely Collaborators Foundation, The Joe and Sandy Samberg Foundation, Bail Capital, KittyHawk Ventures and Satori Neuro. MAPS PBC also announced the company is rebranding and changing its name to Lykos Therapeutics ("Lykos"), effective immediately.